Скачать или смотреть Bladder-Sparing Therapy vs Radical Cystectomy: Long-Term Outcomes in BCG-Unresponsive NMIBC

This video highlights the findings from a recent study published in the BJU International that evaluates the long-term outcomes of bladder-sparing therapy compared with radical cystectomy in patients with BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC).

With BCG-unresponsive disease posing a major clinical challenge, the study examines whether bladder-preserving strategies can offer durable disease control and survival benefits while maintaining quality of life—versus the gold standard treatment of radical cystectomy.

🔍 Key Highlights:

Understanding the prognosis of BCG-unresponsive NMIBC

Long-term survival, recurrence, and progression outcomes

Benefits and risks of bladder-sparing therapy compared to radical cystectomy

Implications for treatment decision-making and patient quality of life

This research provides critical insights for clinicians, patients, and caregivers navigating treatment choices in high-risk NMIBC and may help inform individualized care strategies.